Global Systemic Anti-infective Drugs Supply, Demand and Key Producers, 2023-2029
The global Systemic Anti-infective Drugs market size is expected to reach $ 20690 million by 2029, rising at a market growth of 2.9% CAGR during the forecast period (2023-2029).
Anti-infective drugs are drugs that treat pathogenic infections
This report studies the global Systemic Anti-infective Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Systemic Anti-infective Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Systemic Anti-infective Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Systemic Anti-infective Drugs total production and demand, 2018-2029, (K Units)
Global Systemic Anti-infective Drugs total production value, 2018-2029, (USD Million)
Global Systemic Anti-infective Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Systemic Anti-infective Drugs domestic production, consumption, key domestic manufacturers and share
Global Systemic Anti-infective Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Systemic Anti-infective Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer, Bristol-Myers Squibb, Dechra, Alandalous, Zhengda Tianqing and Luoxin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Systemic Anti-infective Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Systemic Anti-infective Drugs Market, By Region:
1. How big is the global Systemic Anti-infective Drugs market?
2. What is the demand of the global Systemic Anti-infective Drugs market?
3. What is the year over year growth of the global Systemic Anti-infective Drugs market?
4. What is the production and production value of the global Systemic Anti-infective Drugs market?
5. Who are the key producers in the global Systemic Anti-infective Drugs market?
6. What are the growth factors driving the market demand?
Anti-infective drugs are drugs that treat pathogenic infections
This report studies the global Systemic Anti-infective Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Systemic Anti-infective Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Systemic Anti-infective Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Systemic Anti-infective Drugs total production and demand, 2018-2029, (K Units)
Global Systemic Anti-infective Drugs total production value, 2018-2029, (USD Million)
Global Systemic Anti-infective Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Systemic Anti-infective Drugs domestic production, consumption, key domestic manufacturers and share
Global Systemic Anti-infective Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Systemic Anti-infective Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Systemic Anti-infective Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer, Bristol-Myers Squibb, Dechra, Alandalous, Zhengda Tianqing and Luoxin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Systemic Anti-infective Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Systemic Anti-infective Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antibacterial Drugs
- Antifungals
- Antiviral and Antiparasitic Drugs
- Hospital
- Clinic
- Other
- Pfizer
- Sumitomo Dainippon Pharma
- MSD
- Bayer
- Bristol-Myers Squibb
- Dechra
- Alandalous
- Zhengda Tianqing
- Luoxin Pharmaceutical
- Southwest Pharmaceutical
- Guangzhou Baiyun Mountain
- Harbin Pharmaceutical Group
- CSPC
- North China Pharmaceutical
- Sinopharm Group
1. How big is the global Systemic Anti-infective Drugs market?
2. What is the demand of the global Systemic Anti-infective Drugs market?
3. What is the year over year growth of the global Systemic Anti-infective Drugs market?
4. What is the production and production value of the global Systemic Anti-infective Drugs market?
5. Who are the key producers in the global Systemic Anti-infective Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Systemic Anti-infective Drugs Introduction
1.2 World Systemic Anti-infective Drugs Supply & Forecast
1.2.1 World Systemic Anti-infective Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Systemic Anti-infective Drugs Production (2018-2029)
1.2.3 World Systemic Anti-infective Drugs Pricing Trends (2018-2029)
1.3 World Systemic Anti-infective Drugs Production by Region (Based on Production Site)
1.3.1 World Systemic Anti-infective Drugs Production Value by Region (2018-2029)
1.3.2 World Systemic Anti-infective Drugs Production by Region (2018-2029)
1.3.3 World Systemic Anti-infective Drugs Average Price by Region (2018-2029)
1.3.4 North America Systemic Anti-infective Drugs Production (2018-2029)
1.3.5 Europe Systemic Anti-infective Drugs Production (2018-2029)
1.3.6 China Systemic Anti-infective Drugs Production (2018-2029)
1.3.7 Japan Systemic Anti-infective Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Systemic Anti-infective Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Systemic Anti-infective Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Systemic Anti-infective Drugs Demand (2018-2029)
2.2 World Systemic Anti-infective Drugs Consumption by Region
2.2.1 World Systemic Anti-infective Drugs Consumption by Region (2018-2023)
2.2.2 World Systemic Anti-infective Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Systemic Anti-infective Drugs Consumption (2018-2029)
2.4 China Systemic Anti-infective Drugs Consumption (2018-2029)
2.5 Europe Systemic Anti-infective Drugs Consumption (2018-2029)
2.6 Japan Systemic Anti-infective Drugs Consumption (2018-2029)
2.7 South Korea Systemic Anti-infective Drugs Consumption (2018-2029)
2.8 ASEAN Systemic Anti-infective Drugs Consumption (2018-2029)
2.9 India Systemic Anti-infective Drugs Consumption (2018-2029)
3 WORLD SYSTEMIC ANTI-INFECTIVE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Systemic Anti-infective Drugs Production Value by Manufacturer (2018-2023)
3.2 World Systemic Anti-infective Drugs Production by Manufacturer (2018-2023)
3.3 World Systemic Anti-infective Drugs Average Price by Manufacturer (2018-2023)
3.4 Systemic Anti-infective Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Systemic Anti-infective Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Systemic Anti-infective Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Systemic Anti-infective Drugs in 2022
3.6 Systemic Anti-infective Drugs Market: Overall Company Footprint Analysis
3.6.1 Systemic Anti-infective Drugs Market: Region Footprint
3.6.2 Systemic Anti-infective Drugs Market: Company Product Type Footprint
3.6.3 Systemic Anti-infective Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Systemic Anti-infective Drugs Production Value Comparison
4.1.1 United States VS China: Systemic Anti-infective Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Systemic Anti-infective Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Systemic Anti-infective Drugs Production Comparison
4.2.1 United States VS China: Systemic Anti-infective Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Systemic Anti-infective Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Systemic Anti-infective Drugs Consumption Comparison
4.3.1 United States VS China: Systemic Anti-infective Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Systemic Anti-infective Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Systemic Anti-infective Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
4.5 China Based Systemic Anti-infective Drugs Manufacturers and Market Share
4.5.1 China Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
4.6 Rest of World Based Systemic Anti-infective Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Systemic Anti-infective Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibacterial Drugs
5.2.2 Antifungals
5.2.3 Antiviral and Antiparasitic Drugs
5.3 Market Segment by Type
5.3.1 World Systemic Anti-infective Drugs Production by Type (2018-2029)
5.3.2 World Systemic Anti-infective Drugs Production Value by Type (2018-2029)
5.3.3 World Systemic Anti-infective Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Systemic Anti-infective Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Systemic Anti-infective Drugs Production by Application (2018-2029)
6.3.2 World Systemic Anti-infective Drugs Production Value by Application (2018-2029)
6.3.3 World Systemic Anti-infective Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Systemic Anti-infective Drugs Product and Services
7.1.4 Pfizer Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Sumitomo Dainippon Pharma
7.2.1 Sumitomo Dainippon Pharma Details
7.2.2 Sumitomo Dainippon Pharma Major Business
7.2.3 Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Product and Services
7.2.4 Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sumitomo Dainippon Pharma Recent Developments/Updates
7.2.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
7.3 MSD
7.3.1 MSD Details
7.3.2 MSD Major Business
7.3.3 MSD Systemic Anti-infective Drugs Product and Services
7.3.4 MSD Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 MSD Recent Developments/Updates
7.3.6 MSD Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer Systemic Anti-infective Drugs Product and Services
7.4.4 Bayer Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Details
7.5.2 Bristol-Myers Squibb Major Business
7.5.3 Bristol-Myers Squibb Systemic Anti-infective Drugs Product and Services
7.5.4 Bristol-Myers Squibb Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bristol-Myers Squibb Recent Developments/Updates
7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.6 Dechra
7.6.1 Dechra Details
7.6.2 Dechra Major Business
7.6.3 Dechra Systemic Anti-infective Drugs Product and Services
7.6.4 Dechra Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Dechra Recent Developments/Updates
7.6.6 Dechra Competitive Strengths & Weaknesses
7.7 Alandalous
7.7.1 Alandalous Details
7.7.2 Alandalous Major Business
7.7.3 Alandalous Systemic Anti-infective Drugs Product and Services
7.7.4 Alandalous Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Alandalous Recent Developments/Updates
7.7.6 Alandalous Competitive Strengths & Weaknesses
7.8 Zhengda Tianqing
7.8.1 Zhengda Tianqing Details
7.8.2 Zhengda Tianqing Major Business
7.8.3 Zhengda Tianqing Systemic Anti-infective Drugs Product and Services
7.8.4 Zhengda Tianqing Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zhengda Tianqing Recent Developments/Updates
7.8.6 Zhengda Tianqing Competitive Strengths & Weaknesses
7.9 Luoxin Pharmaceutical
7.9.1 Luoxin Pharmaceutical Details
7.9.2 Luoxin Pharmaceutical Major Business
7.9.3 Luoxin Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.9.4 Luoxin Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Luoxin Pharmaceutical Recent Developments/Updates
7.9.6 Luoxin Pharmaceutical Competitive Strengths & Weaknesses
7.10 Southwest Pharmaceutical
7.10.1 Southwest Pharmaceutical Details
7.10.2 Southwest Pharmaceutical Major Business
7.10.3 Southwest Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.10.4 Southwest Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Southwest Pharmaceutical Recent Developments/Updates
7.10.6 Southwest Pharmaceutical Competitive Strengths & Weaknesses
7.11 Guangzhou Baiyun Mountain
7.11.1 Guangzhou Baiyun Mountain Details
7.11.2 Guangzhou Baiyun Mountain Major Business
7.11.3 Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Product and Services
7.11.4 Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Guangzhou Baiyun Mountain Recent Developments/Updates
7.11.6 Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
7.12 Harbin Pharmaceutical Group
7.12.1 Harbin Pharmaceutical Group Details
7.12.2 Harbin Pharmaceutical Group Major Business
7.12.3 Harbin Pharmaceutical Group Systemic Anti-infective Drugs Product and Services
7.12.4 Harbin Pharmaceutical Group Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.12.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.13 CSPC
7.13.1 CSPC Details
7.13.2 CSPC Major Business
7.13.3 CSPC Systemic Anti-infective Drugs Product and Services
7.13.4 CSPC Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 CSPC Recent Developments/Updates
7.13.6 CSPC Competitive Strengths & Weaknesses
7.14 North China Pharmaceutical
7.14.1 North China Pharmaceutical Details
7.14.2 North China Pharmaceutical Major Business
7.14.3 North China Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.14.4 North China Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 North China Pharmaceutical Recent Developments/Updates
7.14.6 North China Pharmaceutical Competitive Strengths & Weaknesses
7.15 Sinopharm Group
7.15.1 Sinopharm Group Details
7.15.2 Sinopharm Group Major Business
7.15.3 Sinopharm Group Systemic Anti-infective Drugs Product and Services
7.15.4 Sinopharm Group Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Sinopharm Group Recent Developments/Updates
7.15.6 Sinopharm Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Systemic Anti-infective Drugs Industry Chain
8.2 Systemic Anti-infective Drugs Upstream Analysis
8.2.1 Systemic Anti-infective Drugs Core Raw Materials
8.2.2 Main Manufacturers of Systemic Anti-infective Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Systemic Anti-infective Drugs Production Mode
8.6 Systemic Anti-infective Drugs Procurement Model
8.7 Systemic Anti-infective Drugs Industry Sales Model and Sales Channels
8.7.1 Systemic Anti-infective Drugs Sales Model
8.7.2 Systemic Anti-infective Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Systemic Anti-infective Drugs Introduction
1.2 World Systemic Anti-infective Drugs Supply & Forecast
1.2.1 World Systemic Anti-infective Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Systemic Anti-infective Drugs Production (2018-2029)
1.2.3 World Systemic Anti-infective Drugs Pricing Trends (2018-2029)
1.3 World Systemic Anti-infective Drugs Production by Region (Based on Production Site)
1.3.1 World Systemic Anti-infective Drugs Production Value by Region (2018-2029)
1.3.2 World Systemic Anti-infective Drugs Production by Region (2018-2029)
1.3.3 World Systemic Anti-infective Drugs Average Price by Region (2018-2029)
1.3.4 North America Systemic Anti-infective Drugs Production (2018-2029)
1.3.5 Europe Systemic Anti-infective Drugs Production (2018-2029)
1.3.6 China Systemic Anti-infective Drugs Production (2018-2029)
1.3.7 Japan Systemic Anti-infective Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Systemic Anti-infective Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Systemic Anti-infective Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Systemic Anti-infective Drugs Demand (2018-2029)
2.2 World Systemic Anti-infective Drugs Consumption by Region
2.2.1 World Systemic Anti-infective Drugs Consumption by Region (2018-2023)
2.2.2 World Systemic Anti-infective Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Systemic Anti-infective Drugs Consumption (2018-2029)
2.4 China Systemic Anti-infective Drugs Consumption (2018-2029)
2.5 Europe Systemic Anti-infective Drugs Consumption (2018-2029)
2.6 Japan Systemic Anti-infective Drugs Consumption (2018-2029)
2.7 South Korea Systemic Anti-infective Drugs Consumption (2018-2029)
2.8 ASEAN Systemic Anti-infective Drugs Consumption (2018-2029)
2.9 India Systemic Anti-infective Drugs Consumption (2018-2029)
3 WORLD SYSTEMIC ANTI-INFECTIVE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Systemic Anti-infective Drugs Production Value by Manufacturer (2018-2023)
3.2 World Systemic Anti-infective Drugs Production by Manufacturer (2018-2023)
3.3 World Systemic Anti-infective Drugs Average Price by Manufacturer (2018-2023)
3.4 Systemic Anti-infective Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Systemic Anti-infective Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Systemic Anti-infective Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Systemic Anti-infective Drugs in 2022
3.6 Systemic Anti-infective Drugs Market: Overall Company Footprint Analysis
3.6.1 Systemic Anti-infective Drugs Market: Region Footprint
3.6.2 Systemic Anti-infective Drugs Market: Company Product Type Footprint
3.6.3 Systemic Anti-infective Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Systemic Anti-infective Drugs Production Value Comparison
4.1.1 United States VS China: Systemic Anti-infective Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Systemic Anti-infective Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Systemic Anti-infective Drugs Production Comparison
4.2.1 United States VS China: Systemic Anti-infective Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Systemic Anti-infective Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Systemic Anti-infective Drugs Consumption Comparison
4.3.1 United States VS China: Systemic Anti-infective Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Systemic Anti-infective Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Systemic Anti-infective Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
4.5 China Based Systemic Anti-infective Drugs Manufacturers and Market Share
4.5.1 China Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
4.6 Rest of World Based Systemic Anti-infective Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Systemic Anti-infective Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibacterial Drugs
5.2.2 Antifungals
5.2.3 Antiviral and Antiparasitic Drugs
5.3 Market Segment by Type
5.3.1 World Systemic Anti-infective Drugs Production by Type (2018-2029)
5.3.2 World Systemic Anti-infective Drugs Production Value by Type (2018-2029)
5.3.3 World Systemic Anti-infective Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Systemic Anti-infective Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Systemic Anti-infective Drugs Production by Application (2018-2029)
6.3.2 World Systemic Anti-infective Drugs Production Value by Application (2018-2029)
6.3.3 World Systemic Anti-infective Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Systemic Anti-infective Drugs Product and Services
7.1.4 Pfizer Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Sumitomo Dainippon Pharma
7.2.1 Sumitomo Dainippon Pharma Details
7.2.2 Sumitomo Dainippon Pharma Major Business
7.2.3 Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Product and Services
7.2.4 Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sumitomo Dainippon Pharma Recent Developments/Updates
7.2.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
7.3 MSD
7.3.1 MSD Details
7.3.2 MSD Major Business
7.3.3 MSD Systemic Anti-infective Drugs Product and Services
7.3.4 MSD Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 MSD Recent Developments/Updates
7.3.6 MSD Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer Systemic Anti-infective Drugs Product and Services
7.4.4 Bayer Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Details
7.5.2 Bristol-Myers Squibb Major Business
7.5.3 Bristol-Myers Squibb Systemic Anti-infective Drugs Product and Services
7.5.4 Bristol-Myers Squibb Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bristol-Myers Squibb Recent Developments/Updates
7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.6 Dechra
7.6.1 Dechra Details
7.6.2 Dechra Major Business
7.6.3 Dechra Systemic Anti-infective Drugs Product and Services
7.6.4 Dechra Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Dechra Recent Developments/Updates
7.6.6 Dechra Competitive Strengths & Weaknesses
7.7 Alandalous
7.7.1 Alandalous Details
7.7.2 Alandalous Major Business
7.7.3 Alandalous Systemic Anti-infective Drugs Product and Services
7.7.4 Alandalous Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Alandalous Recent Developments/Updates
7.7.6 Alandalous Competitive Strengths & Weaknesses
7.8 Zhengda Tianqing
7.8.1 Zhengda Tianqing Details
7.8.2 Zhengda Tianqing Major Business
7.8.3 Zhengda Tianqing Systemic Anti-infective Drugs Product and Services
7.8.4 Zhengda Tianqing Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zhengda Tianqing Recent Developments/Updates
7.8.6 Zhengda Tianqing Competitive Strengths & Weaknesses
7.9 Luoxin Pharmaceutical
7.9.1 Luoxin Pharmaceutical Details
7.9.2 Luoxin Pharmaceutical Major Business
7.9.3 Luoxin Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.9.4 Luoxin Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Luoxin Pharmaceutical Recent Developments/Updates
7.9.6 Luoxin Pharmaceutical Competitive Strengths & Weaknesses
7.10 Southwest Pharmaceutical
7.10.1 Southwest Pharmaceutical Details
7.10.2 Southwest Pharmaceutical Major Business
7.10.3 Southwest Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.10.4 Southwest Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Southwest Pharmaceutical Recent Developments/Updates
7.10.6 Southwest Pharmaceutical Competitive Strengths & Weaknesses
7.11 Guangzhou Baiyun Mountain
7.11.1 Guangzhou Baiyun Mountain Details
7.11.2 Guangzhou Baiyun Mountain Major Business
7.11.3 Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Product and Services
7.11.4 Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Guangzhou Baiyun Mountain Recent Developments/Updates
7.11.6 Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
7.12 Harbin Pharmaceutical Group
7.12.1 Harbin Pharmaceutical Group Details
7.12.2 Harbin Pharmaceutical Group Major Business
7.12.3 Harbin Pharmaceutical Group Systemic Anti-infective Drugs Product and Services
7.12.4 Harbin Pharmaceutical Group Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.12.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.13 CSPC
7.13.1 CSPC Details
7.13.2 CSPC Major Business
7.13.3 CSPC Systemic Anti-infective Drugs Product and Services
7.13.4 CSPC Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 CSPC Recent Developments/Updates
7.13.6 CSPC Competitive Strengths & Weaknesses
7.14 North China Pharmaceutical
7.14.1 North China Pharmaceutical Details
7.14.2 North China Pharmaceutical Major Business
7.14.3 North China Pharmaceutical Systemic Anti-infective Drugs Product and Services
7.14.4 North China Pharmaceutical Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 North China Pharmaceutical Recent Developments/Updates
7.14.6 North China Pharmaceutical Competitive Strengths & Weaknesses
7.15 Sinopharm Group
7.15.1 Sinopharm Group Details
7.15.2 Sinopharm Group Major Business
7.15.3 Sinopharm Group Systemic Anti-infective Drugs Product and Services
7.15.4 Sinopharm Group Systemic Anti-infective Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Sinopharm Group Recent Developments/Updates
7.15.6 Sinopharm Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Systemic Anti-infective Drugs Industry Chain
8.2 Systemic Anti-infective Drugs Upstream Analysis
8.2.1 Systemic Anti-infective Drugs Core Raw Materials
8.2.2 Main Manufacturers of Systemic Anti-infective Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Systemic Anti-infective Drugs Production Mode
8.6 Systemic Anti-infective Drugs Procurement Model
8.7 Systemic Anti-infective Drugs Industry Sales Model and Sales Channels
8.7.1 Systemic Anti-infective Drugs Sales Model
8.7.2 Systemic Anti-infective Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Systemic Anti-infective Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Systemic Anti-infective Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Systemic Anti-infective Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Systemic Anti-infective Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Systemic Anti-infective Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Systemic Anti-infective Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Systemic Anti-infective Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Systemic Anti-infective Drugs Production Market Share by Region (2018-2023)
Table 9. World Systemic Anti-infective Drugs Production Market Share by Region (2024-2029)
Table 10. World Systemic Anti-infective Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Systemic Anti-infective Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Systemic Anti-infective Drugs Major Market Trends
Table 13. World Systemic Anti-infective Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Systemic Anti-infective Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Systemic Anti-infective Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Systemic Anti-infective Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Systemic Anti-infective Drugs Producers in 2022
Table 18. World Systemic Anti-infective Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Systemic Anti-infective Drugs Producers in 2022
Table 20. World Systemic Anti-infective Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Systemic Anti-infective Drugs Company Evaluation Quadrant
Table 22. World Systemic Anti-infective Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Systemic Anti-infective Drugs Production Site of Key Manufacturer
Table 24. Systemic Anti-infective Drugs Market: Company Product Type Footprint
Table 25. Systemic Anti-infective Drugs Market: Company Product Application Footprint
Table 26. Systemic Anti-infective Drugs Competitive Factors
Table 27. Systemic Anti-infective Drugs New Entrant and Capacity Expansion Plans
Table 28. Systemic Anti-infective Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Systemic Anti-infective Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Systemic Anti-infective Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Systemic Anti-infective Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 37. China Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 47. World Systemic Anti-infective Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Systemic Anti-infective Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Systemic Anti-infective Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Systemic Anti-infective Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Systemic Anti-infective Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Systemic Anti-infective Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Systemic Anti-infective Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Systemic Anti-infective Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Systemic Anti-infective Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Systemic Anti-infective Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Systemic Anti-infective Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Systemic Anti-infective Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Systemic Anti-infective Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Systemic Anti-infective Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Systemic Anti-infective Drugs Product and Services
Table 64. Pfizer Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Sumitomo Dainippon Pharma Major Business
Table 69. Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Product and Services
Table 70. Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 72. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 73. MSD Basic Information, Manufacturing Base and Competitors
Table 74. MSD Major Business
Table 75. MSD Systemic Anti-infective Drugs Product and Services
Table 76. MSD Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. MSD Recent Developments/Updates
Table 78. MSD Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Systemic Anti-infective Drugs Product and Services
Table 82. Bayer Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 86. Bristol-Myers Squibb Major Business
Table 87. Bristol-Myers Squibb Systemic Anti-infective Drugs Product and Services
Table 88. Bristol-Myers Squibb Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 91. Dechra Basic Information, Manufacturing Base and Competitors
Table 92. Dechra Major Business
Table 93. Dechra Systemic Anti-infective Drugs Product and Services
Table 94. Dechra Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dechra Recent Developments/Updates
Table 96. Dechra Competitive Strengths & Weaknesses
Table 97. Alandalous Basic Information, Manufacturing Base and Competitors
Table 98. Alandalous Major Business
Table 99. Alandalous Systemic Anti-infective Drugs Product and Services
Table 100. Alandalous Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Alandalous Recent Developments/Updates
Table 102. Alandalous Competitive Strengths & Weaknesses
Table 103. Zhengda Tianqing Basic Information, Manufacturing Base and Competitors
Table 104. Zhengda Tianqing Major Business
Table 105. Zhengda Tianqing Systemic Anti-infective Drugs Product and Services
Table 106. Zhengda Tianqing Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Zhengda Tianqing Recent Developments/Updates
Table 108. Zhengda Tianqing Competitive Strengths & Weaknesses
Table 109. Luoxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Luoxin Pharmaceutical Major Business
Table 111. Luoxin Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 112. Luoxin Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Luoxin Pharmaceutical Recent Developments/Updates
Table 114. Luoxin Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Southwest Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Southwest Pharmaceutical Major Business
Table 117. Southwest Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 118. Southwest Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Southwest Pharmaceutical Recent Developments/Updates
Table 120. Southwest Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 122. Guangzhou Baiyun Mountain Major Business
Table 123. Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Product and Services
Table 124. Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Guangzhou Baiyun Mountain Recent Developments/Updates
Table 126. Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
Table 127. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Pharmaceutical Group Major Business
Table 129. Harbin Pharmaceutical Group Systemic Anti-infective Drugs Product and Services
Table 130. Harbin Pharmaceutical Group Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Pharmaceutical Group Recent Developments/Updates
Table 132. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 133. CSPC Basic Information, Manufacturing Base and Competitors
Table 134. CSPC Major Business
Table 135. CSPC Systemic Anti-infective Drugs Product and Services
Table 136. CSPC Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. CSPC Recent Developments/Updates
Table 138. CSPC Competitive Strengths & Weaknesses
Table 139. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. North China Pharmaceutical Major Business
Table 141. North China Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 142. North China Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. North China Pharmaceutical Recent Developments/Updates
Table 144. Sinopharm Group Basic Information, Manufacturing Base and Competitors
Table 145. Sinopharm Group Major Business
Table 146. Sinopharm Group Systemic Anti-infective Drugs Product and Services
Table 147. Sinopharm Group Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Systemic Anti-infective Drugs Upstream (Raw Materials)
Table 149. Systemic Anti-infective Drugs Typical Customers
Table 150. Systemic Anti-infective Drugs Typical Distributors
Table 1. World Systemic Anti-infective Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Systemic Anti-infective Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Systemic Anti-infective Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Systemic Anti-infective Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Systemic Anti-infective Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Systemic Anti-infective Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Systemic Anti-infective Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Systemic Anti-infective Drugs Production Market Share by Region (2018-2023)
Table 9. World Systemic Anti-infective Drugs Production Market Share by Region (2024-2029)
Table 10. World Systemic Anti-infective Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Systemic Anti-infective Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Systemic Anti-infective Drugs Major Market Trends
Table 13. World Systemic Anti-infective Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Systemic Anti-infective Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Systemic Anti-infective Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Systemic Anti-infective Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Systemic Anti-infective Drugs Producers in 2022
Table 18. World Systemic Anti-infective Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Systemic Anti-infective Drugs Producers in 2022
Table 20. World Systemic Anti-infective Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Systemic Anti-infective Drugs Company Evaluation Quadrant
Table 22. World Systemic Anti-infective Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Systemic Anti-infective Drugs Production Site of Key Manufacturer
Table 24. Systemic Anti-infective Drugs Market: Company Product Type Footprint
Table 25. Systemic Anti-infective Drugs Market: Company Product Application Footprint
Table 26. Systemic Anti-infective Drugs Competitive Factors
Table 27. Systemic Anti-infective Drugs New Entrant and Capacity Expansion Plans
Table 28. Systemic Anti-infective Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Systemic Anti-infective Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Systemic Anti-infective Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Systemic Anti-infective Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 37. China Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Systemic Anti-infective Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Market Share (2018-2023)
Table 47. World Systemic Anti-infective Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Systemic Anti-infective Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Systemic Anti-infective Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Systemic Anti-infective Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Systemic Anti-infective Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Systemic Anti-infective Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Systemic Anti-infective Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Systemic Anti-infective Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Systemic Anti-infective Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Systemic Anti-infective Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Systemic Anti-infective Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Systemic Anti-infective Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Systemic Anti-infective Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Systemic Anti-infective Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Systemic Anti-infective Drugs Product and Services
Table 64. Pfizer Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Sumitomo Dainippon Pharma Major Business
Table 69. Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Product and Services
Table 70. Sumitomo Dainippon Pharma Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 72. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 73. MSD Basic Information, Manufacturing Base and Competitors
Table 74. MSD Major Business
Table 75. MSD Systemic Anti-infective Drugs Product and Services
Table 76. MSD Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. MSD Recent Developments/Updates
Table 78. MSD Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Systemic Anti-infective Drugs Product and Services
Table 82. Bayer Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 86. Bristol-Myers Squibb Major Business
Table 87. Bristol-Myers Squibb Systemic Anti-infective Drugs Product and Services
Table 88. Bristol-Myers Squibb Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 91. Dechra Basic Information, Manufacturing Base and Competitors
Table 92. Dechra Major Business
Table 93. Dechra Systemic Anti-infective Drugs Product and Services
Table 94. Dechra Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dechra Recent Developments/Updates
Table 96. Dechra Competitive Strengths & Weaknesses
Table 97. Alandalous Basic Information, Manufacturing Base and Competitors
Table 98. Alandalous Major Business
Table 99. Alandalous Systemic Anti-infective Drugs Product and Services
Table 100. Alandalous Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Alandalous Recent Developments/Updates
Table 102. Alandalous Competitive Strengths & Weaknesses
Table 103. Zhengda Tianqing Basic Information, Manufacturing Base and Competitors
Table 104. Zhengda Tianqing Major Business
Table 105. Zhengda Tianqing Systemic Anti-infective Drugs Product and Services
Table 106. Zhengda Tianqing Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Zhengda Tianqing Recent Developments/Updates
Table 108. Zhengda Tianqing Competitive Strengths & Weaknesses
Table 109. Luoxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Luoxin Pharmaceutical Major Business
Table 111. Luoxin Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 112. Luoxin Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Luoxin Pharmaceutical Recent Developments/Updates
Table 114. Luoxin Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Southwest Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Southwest Pharmaceutical Major Business
Table 117. Southwest Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 118. Southwest Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Southwest Pharmaceutical Recent Developments/Updates
Table 120. Southwest Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 122. Guangzhou Baiyun Mountain Major Business
Table 123. Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Product and Services
Table 124. Guangzhou Baiyun Mountain Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Guangzhou Baiyun Mountain Recent Developments/Updates
Table 126. Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
Table 127. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Pharmaceutical Group Major Business
Table 129. Harbin Pharmaceutical Group Systemic Anti-infective Drugs Product and Services
Table 130. Harbin Pharmaceutical Group Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Pharmaceutical Group Recent Developments/Updates
Table 132. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 133. CSPC Basic Information, Manufacturing Base and Competitors
Table 134. CSPC Major Business
Table 135. CSPC Systemic Anti-infective Drugs Product and Services
Table 136. CSPC Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. CSPC Recent Developments/Updates
Table 138. CSPC Competitive Strengths & Weaknesses
Table 139. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. North China Pharmaceutical Major Business
Table 141. North China Pharmaceutical Systemic Anti-infective Drugs Product and Services
Table 142. North China Pharmaceutical Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. North China Pharmaceutical Recent Developments/Updates
Table 144. Sinopharm Group Basic Information, Manufacturing Base and Competitors
Table 145. Sinopharm Group Major Business
Table 146. Sinopharm Group Systemic Anti-infective Drugs Product and Services
Table 147. Sinopharm Group Systemic Anti-infective Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Systemic Anti-infective Drugs Upstream (Raw Materials)
Table 149. Systemic Anti-infective Drugs Typical Customers
Table 150. Systemic Anti-infective Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Systemic Anti-infective Drugs Picture
Figure 2. World Systemic Anti-infective Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Systemic Anti-infective Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 5. World Systemic Anti-infective Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Systemic Anti-infective Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Systemic Anti-infective Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 10. China Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 12. Systemic Anti-infective Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Systemic Anti-infective Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Systemic Anti-infective Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Systemic Anti-infective Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Systemic Anti-infective Drugs Markets in 2022
Figure 26. United States VS China: Systemic Anti-infective Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Systemic Anti-infective Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Systemic Anti-infective Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 32. World Systemic Anti-infective Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Systemic Anti-infective Drugs Production Value Market Share by Type in 2022
Figure 34. Antibacterial Drugs
Figure 35. Antifungals
Figure 36. Antiviral and Antiparasitic Drugs
Figure 37. World Systemic Anti-infective Drugs Production Market Share by Type (2018-2029)
Figure 38. World Systemic Anti-infective Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World Systemic Anti-infective Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Systemic Anti-infective Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Systemic Anti-infective Drugs Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Systemic Anti-infective Drugs Production Market Share by Application (2018-2029)
Figure 46. World Systemic Anti-infective Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Systemic Anti-infective Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Systemic Anti-infective Drugs Industry Chain
Figure 49. Systemic Anti-infective Drugs Procurement Model
Figure 50. Systemic Anti-infective Drugs Sales Model
Figure 51. Systemic Anti-infective Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Systemic Anti-infective Drugs Picture
Figure 2. World Systemic Anti-infective Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Systemic Anti-infective Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 5. World Systemic Anti-infective Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Systemic Anti-infective Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Systemic Anti-infective Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 10. China Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Systemic Anti-infective Drugs Production (2018-2029) & (K Units)
Figure 12. Systemic Anti-infective Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Systemic Anti-infective Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Systemic Anti-infective Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Systemic Anti-infective Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Systemic Anti-infective Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Systemic Anti-infective Drugs Markets in 2022
Figure 26. United States VS China: Systemic Anti-infective Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Systemic Anti-infective Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Systemic Anti-infective Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Systemic Anti-infective Drugs Production Market Share 2022
Figure 32. World Systemic Anti-infective Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Systemic Anti-infective Drugs Production Value Market Share by Type in 2022
Figure 34. Antibacterial Drugs
Figure 35. Antifungals
Figure 36. Antiviral and Antiparasitic Drugs
Figure 37. World Systemic Anti-infective Drugs Production Market Share by Type (2018-2029)
Figure 38. World Systemic Anti-infective Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World Systemic Anti-infective Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Systemic Anti-infective Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Systemic Anti-infective Drugs Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Systemic Anti-infective Drugs Production Market Share by Application (2018-2029)
Figure 46. World Systemic Anti-infective Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World Systemic Anti-infective Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Systemic Anti-infective Drugs Industry Chain
Figure 49. Systemic Anti-infective Drugs Procurement Model
Figure 50. Systemic Anti-infective Drugs Sales Model
Figure 51. Systemic Anti-infective Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
